Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (191-200 of 338) with videos related to

Pageof 34
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 14, 2009
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancerJong-Mu Sun, Do-Youn Oh, Se-Hoon Lee, et al.
Journal of Cancer Research and Clinical Oncology|June 1, 2011
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancySoohyeon Lee, Youngwook Kim, Jong-Mu Sun, et al.
Cancer Medicine|April 19, 2022
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitorsMinsuk Kwon, Bo Mi Ku, Steve Olsen, et al.
Urologic Oncology|December 24, 2013
FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapyJi-Youn Sung, Jong-Mu Sun, Byong Chang Jeong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySeung Tae Kim, Ji Eun Uhm, Jeeyun Lee, et al.
Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.
The Korean Journal of Internal Medicine|April 4, 2020
Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancerSung Hee Lim, Jong-Mu Sun, Joohyun Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experienceYong-Pyo Lee, Byeong-Ho Jeong, Yeonghee Eun, et al.
The Annals of Thoracic Surgery|February 21, 2026
Prognosis of Isolated Cervical Node Recurrence Following Esophagectomy With Two-Field Lymphadenectomy for Esophageal Squamous Cell CarcinomaYeong Jeong Jeon, Jeong A Son, Junghee Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2022
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 TrialJiyun Lee, Jiae Koh, Hee Kyung Kim, et al.
Pageof 34

Showing results (191-200 of 338) with videos related to

Sort By:
Pageof 34
Lung Cancer (Amsterdam, Netherlands)|August 14, 2009
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancerJong-Mu Sun, Do-Youn Oh, Se-Hoon Lee, et al.
Journal of Cancer Research and Clinical Oncology|June 1, 2011
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancySoohyeon Lee, Youngwook Kim, Jong-Mu Sun, et al.
Cancer Medicine|April 19, 2022
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitorsMinsuk Kwon, Bo Mi Ku, Steve Olsen, et al.
Urologic Oncology|December 24, 2013
FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapyJi-Youn Sung, Jong-Mu Sun, Byong Chang Jeong, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySeung Tae Kim, Ji Eun Uhm, Jeeyun Lee, et al.
Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.
The Korean Journal of Internal Medicine|April 4, 2020
Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancerSung Hee Lim, Jong-Mu Sun, Joohyun Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experienceYong-Pyo Lee, Byeong-Ho Jeong, Yeonghee Eun, et al.
The Annals of Thoracic Surgery|February 21, 2026
Prognosis of Isolated Cervical Node Recurrence Following Esophagectomy With Two-Field Lymphadenectomy for Esophageal Squamous Cell CarcinomaYeong Jeong Jeon, Jeong A Son, Junghee Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2022
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 TrialJiyun Lee, Jiae Koh, Hee Kyung Kim, et al.
Pageof 34